Study evaluating immunological response of HSP105-peptide-loaded-dendritic-cell-vaccine in patients with advanced Colorectal and Oesophageal cancer
Latest Information Update: 07 Nov 2019
At a glance
- Drugs HSP105 peptide-loaded dendritic cell vaccine (Primary) ; Montanide ISA-51
- Indications Colorectal cancer; Oesophageal cancer
- Focus Pharmacodynamics
Most Recent Events
- 07 Nov 2019 New trial record
- 01 Oct 2019 Results published in the Cancer Science